'An Irrelevant Company': Jim Cramer Says Snap Is 'Not Investable'

Zinger Key Points
  • Aflac Incorporated is "not my fave," says Jim Cramer.
  • Main Street Capital is a "business development company. I have never trusted business development companies," says Cramer.

On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended buying Applied Materials, Inc. AMAT. “I think that the company is doing well. I think that the government is not crazy about their posture, because they do so much business in China,” he added.

When asked about Aflac Incorporated AFL, he said, “It's not my fave, not my fave. I do like Chubb Ltd CB in the insurance business. But that's really about it.”

“We're going to steer clear of Albemarle ALB,” Cramer said.

When asked about Elevance Health, Inc. ELV, he said, “UnitedHealth Group Inc UNH is still the cream of the crop.”

Snap SNAP is “really not, it's not investable,” he said. “They seem like an irrelevant company.”

The "Mad Money" host said Main Street Capital Corporation MAIN is a “business development company. I have never trusted business development companies,”

Cramer said Alibaba Group Holding Limited ABBA is an "incredibly cheap stock, alright. They're going to report a great number, and then there's always going to be something that people don't like, and then they sell it down."

Price Action:

  • Aflac shares fell 0.1% to settle at $101.19 on Monday.
  • Elevance Health shares fell 1.2% to close at $525.85.
  • Albemarle shares fell 6.9% to close at $76.00.
  • Snap shares fell 0.3% to close at $9.02.
  • Applied Materials shares gained 1% to settle at $193.09 on Monday.
  • Main Street Capital shares fell 0.5% to close at $48.35 on Monday.
  • Alibaba shares gained 1.2% to close at $80.91.

Read Next:

Photo: Shutterstock

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Long IdeasNewsTop StoriesMarketsMediaTrading IdeasCNBCmad money Lightning RoundStories That MatterJim Cramer
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!